-
1
-
2
Comparative transcriptome atlas as an assistive modality for complex classification of rare kidney cancers
出版事項 2025主題: “…Cancer Diagnosis…”
-
3
Figure S2 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
4
Supplementary Tables 1 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Canc...
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
5
Figure S4 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
6
Figure S5 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
7
Figure S6 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
8
Figure S1 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
9
Figure S3 from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2<sup>+</sup> Breast Cancer
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
10
-
11
Supplementary Tables 1-3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH S...
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
12
Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathwa...
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
13
Figure S3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathwa...
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
14
Figure S1 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathwa...
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
15
Supplementary Data S1-S2 from Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
16
-
17
Supplementary Table S17 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
18
Supplementary Table S15 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
19
Supplementary Table S13 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
出版事項 2025主題: “…Cancer Detection and Diagnosis…”
-
20
Supplementary Table S10 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
出版事項 2025主題: “…Cancer Detection and Diagnosis…”